Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
May 30, 2025
May 30, 2025
BOSTON, Massachusetts, May 30 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release on May 29, 2025:
* * *
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve common thresholds of cost-effectiveness if priced between $3,2 . . .
* * *
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Secondary Progressive Multiple Sclerosis
There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve common thresholds of cost-effectiveness if priced between $3,2 . . .